EOSE:NASDAQEos Energy Enterprises, Inc. Analysis
Data as of 2026-06-14 - not real-time
$6.06
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Eos Energy Enterprises posted a spectacular 445% YoY increase in first‑quarter revenue, reaching $57 million and delivering a $10 million improvement in gross loss quarter‑to‑quarter.
However, the company’s financial health remains fragile: gross, operating and profit margins are all negative, cash flow is negative, and the balance of debt versus equity is extreme. Technical analysis shows a bearish MACD, a low‑14‑day RSI (≈38), a 30‑day volatility of over 119%, and a very high beta (>4), while volume is on a declining trend. The market sentiment is marked by an “Extreme Greed” index (≈90) and a 58% upside‑to‑downside potential, suggesting speculative pressure despite the poor fundamentals.
However, the company’s financial health remains fragile: gross, operating and profit margins are all negative, cash flow is negative, and the balance of debt versus equity is extreme. Technical analysis shows a bearish MACD, a low‑14‑day RSI (≈38), a 30‑day volatility of over 119%, and a very high beta (>4), while volume is on a declining trend. The market sentiment is marked by an “Extreme Greed” index (≈90) and a 58% upside‑to‑downside potential, suggesting speculative pressure despite the poor fundamentals.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 9/10
Key Factors
- bearish MACD and low RSI indicating technical downside
- extremely high volatility and beta increasing market risk
- extreme greed index signaling unsustainable speculative pressure
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- massive revenue surge but persistently negative margins
- high max drawdown (~‑77%) indicating deep downside risk
- ongoing negative cash flow and debt load
Long Term
> 3 yearsPositive
Model confidence: 5/10
Key Factors
- innovative zinc‑based long‑duration storage technology
- potential market demand for utility‑scale energy storage
- opportunity to acquire at a low price relative to long‑term support level
Key Metrics & Analysis
Financial Health
Revenue Growth444.70%
Profit Margin-296.13%
P/E Ratio-127.7
ROA-33.45%
P/B Ratio-2.4
Op. Cash Flow$-302000992
Free Cash Flow$-281868256
Industry P/E30.6
Technical Analysis
TrendNeutral
RSI38.3
Support$5.88
Resistance$9.69
MA 20$7.67
MA 50$7.08
MA 200$10.69
MACDBearish
VolumeDecreasing
Fear & Greed Index89.86
Valuation
Target Price$9.63
Upside/Downside58.83%
GradeUndervalued
TypeBlend
Risk Assessment
Beta4.03
Volatility119.01%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.